← Back to Search

Behavioral Intervention

Music Therapy for Lung Cancer

N/A
Waitlist Available
Led By Teresa Lesiuk, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range of 40 to 80 years old
English and Spanish speakers only
Must not have
Patients in respiratory failure
Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 1 month
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess how VIT & TS can improve respiratory function & quality of life in lung cancer patients. #MusicTherapy #LungCancer

Who is the study for?
This trial is for lung cancer patients, stages I-III, who've had certain surgeries like thoracentesis or lobectomy within the last year. They must be aged 40-80 and have less than five years of voice training. Excluded are those in respiratory failure, with severe neurological/hearing issues, dysphonia, no tech access or quiet space, and prisoners.
What is being tested?
The study tests how Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) affect breathing function short-term in lung cancer patients. It also looks at how these music therapies might improve their respiratory quality of life.
What are the potential side effects?
Since this trial involves non-invasive music therapy interventions like singing and vocal exercises rather than drugs or surgery, significant side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 40 and 80 years old.
Select...
I speak English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am experiencing severe difficulty breathing.
Select...
I have voice problems or have had my voice box removed.
Select...
I am either younger than 40 or older than 80.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Dyspnea measured by Cancer Dyspnea Scale
Change in Dyspnea measured by Dyspnea-12 Questionnaire
Change in Dyspnea measured by Modified Borg Scale
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vocal Therapy GroupExperimental Treatment2 Interventions
Participants in this group will receive Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) for up to three weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vocal Intonation Therapy (VIT)
2024
N/A
~10
Therapeutic Singing (TS)
2024
N/A
~10

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
948 Previous Clinical Trials
427,843 Total Patients Enrolled
Teresa Lesiuk, PhDPrincipal InvestigatorUniversity of Miami
1 Previous Clinical Trials
40 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top